title: Colorectal cancer in colitis: a relic of the past?
abstract: The incidence of dysplasia and colorectal cancer in patients with long-standing colitis seems to be decreasing and controversy surrounds our detection and management strategies. Dysplasia is rarer, flatter, and smaller than in previous decades. Current surveillance guidelines, onerous in terms of colonoscopic workload and an emphasis on random biopsies, have yet to be shown to prevent colon cancers and colon cancer death in these patients. The evidence base for adjunct techniques such as chromoendoscopy is strong but adoption has been slow. We need to better risk-stratify patients with colitis and direct diminishing medical resources accordingly. Modulating dysplasia and cancer risk will involve optimizing medical therapies and focusing our colonoscopic efforts on those who will most likely benefit.
authors.affiliation: Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai, New York, New York.
authors.forename: James F
authors.initials: JF
authors.lastname: Marion
mesh_terms: D000818:Animals; D003092:Colitis / Q000150:complications*; D015179:Colorectal Neoplasms / Q000209:etiology*; D006801:Humans; D012307:Risk Factors